A detailed regimen of isotretinoin for the successful treatment of severe keratosis pilaris.
Clin Exp Dermatol
; 47(3): 619-621, 2022 Mar.
Article
en En
| MEDLINE
| ID: mdl-34780085
ABSTRACT
Although a well-known recommended treatment option, there are currently no studies that describe the detailed regimen of isotretinoin for the treatment of primary keratosis pilaris. Based on previous studies involving other hyperkeratotic disorders, this report describes a safe and effective treatment course of isotretinoin for severe keratosis pilaris.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Anomalías Múltiples
/
Isotretinoína
/
Fármacos Dermatológicos
/
Cejas
/
Enfermedad de Darier
Límite:
Adolescent
/
Female
/
Humans
Idioma:
En
Revista:
Clin Exp Dermatol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos